{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:21:49Z","timestamp":1794255709760,"version":"4.9.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["U54 DK083909"],"award-info":[{"award-number":["U54 DK083909"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1 TR001439"],"award-info":[{"award-number":["UL1 TR001439"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017559","name":"Recordati Rare Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ymgme.2026.110280","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:53:28Z","timestamp":1790265208000},"page":"110280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Intravenous hemin for prevention of frequent attacks of acute hepatic porphyria - a double-blind placebo controlled pilot study"],"prefix":"10.1016","volume":"149","author":[{"given":"Akshata","family":"Moghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csilla","family":"Kormos-Hallberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Villasante-Tezanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl E.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2026.110280_bb0005","series-title":"Williams Hematology","first-page":"961","article-title":"The porphyrias","author":"Phillips","year":"2021"},{"issue":"12","key":"10.1016\/j.ymgme.2026.110280_bb0010","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.amjmed.2014.06.036","article-title":"Acute porphyrias in the USA: features of 108 subjects from porphyrias consortium","volume":"127","author":"Bonkovsky","year":"2014","journal-title":"Am. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110280_bb0015","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ymgme.2019.07.002","article-title":"Acute hepatic porphyrias: current diagnosis & management","volume":"128","author":"Anderson","year":"2019","journal-title":"Mol. Genet. Metab."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110280_bb0020","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1016\/S2352-3026(26)00044-X","article-title":"Guidelines for the management of acute porphyria: recommendations from the International Porphyria Network","volume":"13","author":"Edel","year":"2026","journal-title":"Lancet Haematol."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110280_bb0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM198607243150406","article-title":"Instability of hematin used in the treatment of acute hepatic porphyria","volume":"315","author":"Goetsch","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110280_bb0030","first-page":"361","article-title":"The inactivation of hemostatic factors by hematin","volume":"102","author":"Green","year":"1983","journal-title":"J. Lab. Clin. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110280_bb0035","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1084\/jem.163.3.724","article-title":"Hematin-derived anticoagulant. Generation in vitro and in vivo","volume":"163","author":"Jones","year":"1986","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.ymgme.2026.110280_bb0040","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0002-9343(88)80092-5","article-title":"Thrombophlebitis and disturbed hemostasis following administration of intravenous hematin in normal volunteers","volume":"85","author":"Simionatto","year":"1988","journal-title":"Am. J. Med."},{"issue":"8","key":"10.1016\/j.ymgme.2026.110280_bb0045","first-page":"1050","article-title":"Intravenous heme-albumin in acute intermittent porphyria: evidence for repletion of hepatic hemoproteins and regulatory heme pools","volume":"86","author":"Bonkovsky","year":"1991","journal-title":"Am. J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ymgme.2026.110280_bb0050","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7326\/0003-4819-144-7-200604040-00023","article-title":"Reconstitution of hematin for intravenous infusion","volume":"144","author":"Anderson","year":"2006","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110280_bb0055","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s12325-008-0094-y","article-title":"Physicochemical properties, pharmacokinetics, and pharmacodynamics of intravenous hematin: a literature review","volume":"25","author":"Siegert","year":"2008","journal-title":"Adv. Ther."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110280_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-1007140","article-title":"Acute porphyria: treatment with heme","volume":"18","author":"Tenhunen","year":"1998","journal-title":"Semin. Liver Dis."},{"issue":"11","key":"10.1016\/j.ymgme.2026.110280_bb0065","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1073\/pnas.68.11.2725","article-title":"Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin","volume":"68","author":"Bonkowsky","year":"1971","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ymgme.2026.110280_bb0070","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-83-1-20","article-title":"Effects of hematin in hepatic porphyria. Further studies","volume":"83","author":"Dhar","year":"1975","journal-title":"Ann. Intern. Med."},{"issue":"3","key":"10.1016\/j.ymgme.2026.110280_bb0075","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00005792-197905000-00005","article-title":"Hematin therapy for acute porphyria","volume":"58","author":"Lamon","year":"1979","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"10.1016\/j.ymgme.2026.110280_bb0080","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1001\/archinte.1993.00410170078008","article-title":"Early administration of heme arginate for acute porphyric attacks","volume":"153","author":"Mustajoki","year":"1993","journal-title":"Arch. Intern. Med."},{"issue":"8088","key":"10.1016\/j.ymgme.2026.110280_bb0085","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0140-6736(78)92217-1","article-title":"Prevention of acute porphyric attacks by intravenous haematin","volume":"2","author":"Lamon","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.ymgme.2026.110280_bb0090","first-page":"57","article-title":"Audit of the use of regular haem arginate infusions in patients with acute porphyria to prevent recurrent symptoms","volume":"22","author":"Marsden","year":"2015","journal-title":"JIMD Rep."},{"key":"10.1016\/j.ymgme.2026.110280_bb0095","article-title":"Benefits of prophylactic heme therapy in severe acute intermittent porphyria","volume":"19","author":"Yarra","year":"2019","journal-title":"Mol. Genet. Metab. Rep."},{"key":"10.1016\/j.ymgme.2026.110280_bb0100","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.712305","article-title":"Prophylactic heme arginate infusion for acute intermittent porphyria","volume":"12","author":"Kuo","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.ymgme.2026.110280_bb0105","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000327","article-title":"Long-term management and treatment of acute intermittent porphyria with recurring attacks using pharmacological prophylaxis","volume":"7","author":"Kuo","year":"2023","journal-title":"Hepatol. Commun."},{"issue":"1","key":"10.1016\/j.ymgme.2026.110280_bb0110","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13023-024-03284-w","article-title":"Long-term follow-up of givosiran treatment in patients with acute intermittent porphyria from a phase 1\/2, 48-month open-label extension study","volume":"19","author":"Sardh","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"issue":"9","key":"10.1016\/j.ymgme.2026.110280_bb0115","doi-asserted-by":"crossref","first-page":"801 e19","DOI":"10.1016\/j.amjmed.2006.05.026","article-title":"Open-label study of hemin for acute porphyria: clinical practice implications","volume":"119","author":"Anderson","year":"2006","journal-title":"Am. J. Med."},{"issue":"8650","key":"10.1016\/j.ymgme.2026.110280_bb0120","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0140-6736(89)92688-3","article-title":"Controlled trial of haem arginate in acute hepatic porphyria","volume":"1","author":"Herrick","year":"1989","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ymgme.2026.110280_bb0125","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1056\/NEJMoa1913147","article-title":"Phase 3 trial of RNAi therapeutic givosiran for acute intermittent porphyria","volume":"382","author":"Balwani","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ymgme.2026.110280_bb0130","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archderm.1980.01640290053010","article-title":"A plasma porphyrin fluorescence marker for variegate porphyria","volume":"116","author":"Poh-Fitzpatrick","year":"1980","journal-title":"Arch. Dermatol."}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719226005639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:30:36Z","timestamp":1794252636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719226005639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1096719226005639"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110280","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous hemin for prevention of frequent attacks of acute hepatic porphyria - a double-blind placebo controlled pilot study","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2026.110280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110280"}}